Huue has raised $18.0M in total across 2 funding rounds.
Huue's investors include Accel, Aleph VC, Bessemer Venture Partners, Coatue, Company Capital, Corner Ventures, General Catalyst, Intuit Ventures, SOSV, Julia Kagan, Kaszek Ventures, Mayfield.
# Huey: Biotechnology Company Overview
Huue is a biotechnology company, not a traditional technology firm. It uses synthetic biology and bioengineering to create sustainable dyes, primarily biosynthetic indigo for the denim industry, rather than developing software, hardware, or digital platforms[1][3].
Huue addresses a critical environmental problem in fashion: conventional indigo dye production relies on toxic chemicals like benzene, formaldehyde, and cyanide, while consuming 75 times the amount of petroleum per kilogram of indigo produced[5]. The company's solution uses nature-inspired bioengineering to program microbes that consume sugar and enzymatically produce indigo, eliminating the need for petroleum and toxic chemical reducing agents[5].
The company serves denim manufacturers and fashion brands seeking sustainable alternatives. Huue's biosynthetic indigo has five times less toxicity potential than chemical sources while performing just as effectively in existing manufacturing processes—a critical advantage for industry adoption[5]. Beyond denim, Huue is expanding into food dyes and partnering with Gingko Bioworks to broaden its color platform[1].
Huue was founded in 2019 (though some sources reference 2018 as an earlier inception date) by Tammy Melody Hsu and Michelle Zhu, alongside co-founders Arthur Fong, Bernardo Cervantes, John Dueber, Luke Latimer, Ramya Prathuri, Shyam Bhakta, Terry Johnson, and Zachary Russ[2][4].
The company emerged from Hsu's doctoral research at UC Berkeley in bioengineering, where she studied how plants naturally produce indigo and engineered microbes to replicate this process[4]. Zhu brought complementary expertise in business operations and strategy, along with a family background in textiles and apparel—her parents founded an urban streetwear brand in the late 1990s[4]. In early 2019, Hsu recognized growing demand from fashion brands for sustainable dye technology, prompting the two to formalize their collaboration[4].
Huue operates at the intersection of synthetic biology and sustainable fashion—two accelerating trends reshaping industrial manufacturing. The fashion industry's environmental footprint has become a critical concern for both regulators and consumers, creating urgency around supply chain transformation[2].
The company exemplifies how biotech innovation can solve legacy industrial problems by mimicking natural processes rather than replacing them with entirely new infrastructure. This approach aligns with broader momentum toward circular economy principles and regenerative manufacturing. Huue's success could influence how other chemical-intensive industries—textiles, food production, cosmetics—approach sustainability through biological engineering rather than chemical substitution.
Huue has secured $14.6 million in Series A funding (as of mid-2022) led by Material Impact, with total funding reaching $2.6 million across earlier rounds[1][4]. The company was scaling from approximately 15 employees toward 25 by 2023[4].
The path forward depends on manufacturing partnerships and market adoption. If major denim producers integrate Huue's indigo at scale, the company could establish a blueprint for biotech-driven sustainability in fashion. Expansion into food dyes and other color applications suggests ambitions beyond denim—positioning Huue as a platform for biosynthetic color across industries. The timing is favorable: regulatory pressure on textile dyeing, consumer demand for sustainable fashion, and maturing synthetic biology capabilities all work in Huue's favor. The critical question is whether cost parity and supply chain integration can match the environmental and safety advantages.
Huue has raised $18.0M across 2 funding rounds. Most recently, it raised $15.0M Series A in July 2022.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jul 1, 2022 | $15.0M Series A | Accel, Aleph VC, Bessemer Venture Partners, Coatue, Company Capital, Corner Ventures, General Catalyst, Intuit Ventures, SOSV, Julia Kagan | |
| Nov 1, 2019 | $3.0M Seed | Kaszek Ventures, Mayfield, Tiger Global Management, Ahmir Khalib Thompson, Jeff Bezos, Marcos Galperin |
